Sun Pharma Advanced Research Company Limited (SPARC.BO)
INR 143.0
(0.11%)
INR 143.0
(0.11%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.07 Billion INR | 5.79% |
| 2022 | 2.9 Billion INR | 40.76% |
| 2021 | 2.06 Billion INR | 5.07% |
| 2020 | 1.96 Billion INR | -1.13% |
| 2019 | 1.98 Billion INR | 13.95% |
| 2018 | 1.74 Billion INR | -5.57% |
| 2017 | 1.84 Billion INR | 23.24% |
| 2016 | 1.5 Billion INR | 61.26% |
| 2015 | 930.16 Million INR | 21.55% |
| 2014 | 765.25 Million INR | 0.6% |
| 2013 | 760.68 Million INR | -22.11% |
| 2012 | 976.59 Million INR | 3.19% |
| 2011 | 946.38 Million INR | 57.0% |
| 2010 | 602.81 Million INR | 23.27% |
| 2009 | 489.03 Million INR | 23.53% |
| 2008 | 395.87 Million INR | 12.63% |
| 2007 | 351.49 Million INR | 2199.88% |
| 2006 | 15.28 Million INR | 0.0% |
| 2005 | - INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 513.79 Million INR | -20.83% |
| 2024 Q2 | 689.8 Million INR | -140.83% |
| 2023 Q4 | 649 Million INR | -25.32% |
| 2023 Q2 | 911.5 Million INR | 4.67% |
| 2023 Q1 | 870.8 Million INR | 17.76% |
| 2023 FY | 3.07 Billion INR | 5.79% |
| 2023 Q3 | 869 Million INR | -4.66% |
| 2022 FY | 2.9 Billion INR | 40.76% |
| 2022 Q1 | 705.9 Million INR | 31.74% |
| 2022 Q2 | 642.6 Million INR | -8.97% |
| 2022 Q3 | 911.5 Million INR | 41.85% |
| 2022 Q4 | 739.43 Million INR | -18.88% |
| 2021 FY | 2.06 Billion INR | 5.07% |
| 2021 Q1 | 514.3 Million INR | 12.4% |
| 2021 Q3 | 501.3 Million INR | -7.36% |
| 2021 Q2 | 541.1 Million INR | 5.21% |
| 2021 Q4 | 535.84 Million INR | 6.89% |
| 2020 FY | 1.96 Billion INR | -1.13% |
| 2020 Q1 | 583.2 Million INR | 21.94% |
| 2020 Q2 | 438.7 Million INR | -24.78% |
| 2020 Q3 | 481.2 Million INR | 9.69% |
| 2020 Q4 | 457.56 Million INR | -4.91% |
| 2019 FY | 1.98 Billion INR | 13.95% |
| 2019 Q1 | 602.8 Million INR | 74.27% |
| 2019 Q4 | 478.25 Million INR | 7.81% |
| 2019 Q3 | 443.6 Million INR | -3.73% |
| 2019 Q2 | 460.8 Million INR | -23.56% |
| 2018 Q1 | 489.6 Million INR | -3.22% |
| 2018 FY | 1.74 Billion INR | -5.57% |
| 2018 Q4 | 345.89 Million INR | -26.69% |
| 2018 Q3 | 471.8 Million INR | 7.64% |
| 2018 Q2 | 438.3 Million INR | -10.48% |
| 2017 Q1 | 463.8 Million INR | 28.26% |
| 2017 FY | 1.84 Billion INR | 23.24% |
| 2017 Q4 | 505.9 Million INR | 17.57% |
| 2017 Q3 | 430.3 Million INR | -4.14% |
| 2017 Q2 | 448.9 Million INR | -3.21% |
| 2016 Q3 | 370.5 Million INR | 7.02% |
| 2016 FY | 1.5 Billion INR | 61.26% |
| 2016 Q4 | 361.6 Million INR | -2.4% |
| 2016 Q2 | 346.2 Million INR | 8.46% |
| 2016 Q1 | 319.2 Million INR | 29.76% |
| 2015 Q3 | 214.5 Million INR | -21.14% |
| 2015 Q2 | 272 Million INR | 31.15% |
| 2015 Q4 | 246 Million INR | 14.69% |
| 2015 FY | 930.16 Million INR | 21.55% |
| 2015 Q1 | 207.4 Million INR | -2.49% |
| 2014 Q4 | 212.69 Million INR | 15.53% |
| 2014 FY | 765.25 Million INR | 0.6% |
| 2014 Q3 | 184.1 Million INR | -4.26% |
| 2014 Q2 | 192.3 Million INR | 7.55% |
| 2014 Q1 | 178.8 Million INR | -77.97% |
| 2013 Q4 | 811.55 Million INR | 422.91% |
| 2013 FY | 760.68 Million INR | -22.11% |
| 2013 Q2 | 163.5 Million INR | 4.61% |
| 2013 Q1 | 156.3 Million INR | -72.06% |
| 2013 Q3 | 155.2 Million INR | -5.08% |
| 2012 Q1 | 143.3 Million INR | -75.75% |
| 2012 Q3 | 141.1 Million INR | 4.99% |
| 2012 Q4 | 559.39 Million INR | 296.45% |
| 2012 FY | 976.59 Million INR | 3.19% |
| 2012 Q2 | 134.4 Million INR | -6.21% |
| 2011 Q3 | 122.4 Million INR | 0.0% |
| 2011 FY | 946.38 Million INR | 57.0% |
| 2011 Q4 | 590.98 Million INR | 382.83% |
| 2010 FY | 602.81 Million INR | 23.27% |
| 2009 FY | 489.03 Million INR | 23.53% |
| 2008 FY | 395.87 Million INR | 12.63% |
| 2007 FY | 351.49 Million INR | 2199.88% |
| 2006 FY | 15.28 Million INR | 0.0% |
| 2005 FY | - INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 80.612% |
| Aurobindo Pharma Limited | 39.23 Billion INR | 92.158% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | 73.569% |
| Granules India Limited | 7.18 Billion INR | 57.162% |
| Indoco Remedies Limited | 4.74 Billion INR | 35.209% |
| Achyut Healthcare Limited | 1.6 Million INR | -191124.363% |
| Ajanta Pharma Limited | 30.46 Billion INR | 89.9% |
| Alkem Laboratories Limited | 32.83 Billion INR | 90.63% |
| Alpa Laboratories Limited | 156.14 Million INR | -1870.451% |
| Brooks Laboratories Limited | 51.18 Million INR | -5911.723% |
| AstraZeneca Pharma India Limited | 2.6 Billion INR | -18.32% |
| Bajaj HealthCare Limited | 985.34 Million INR | -212.256% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -116.795% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 96.791% |
| Eris Lifesciences Limited | 4.94 Billion INR | 37.754% |
| FDC Limited | 5.34 Billion INR | 42.474% |
| Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 95.446% |
| Gufic Biosciences Limited | 1.07 Billion INR | -185.494% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -44.846% |
| Ipca Laboratories Limited | 13.91 Billion INR | 77.888% |
| Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | -297.823% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -6566.089% |
| Lasa Supergenerics Limited | 291.17 Million INR | -956.688% |
| Laurus Labs Limited | 3.01 Billion INR | -2.192% |
| Lupin Limited | 95.67 Billion INR | 96.784% |
| Mankind Pharma Limited | 23.15 Billion INR | 86.711% |
| Medicamen Biotech Limited | 335.16 Million INR | -817.99% |
| Medico Remedies Limited | 161.84 Million INR | -1801.09% |
| Megasoft Limited | 49.52 Million INR | -6112.244% |
| NATCO Pharma Limited | 10.05 Billion INR | 69.409% |
| Piramal Pharma Limited | 19.91 Billion INR | 84.55% |
| RPG Life Sciences Limited | 1.63 Billion INR | -88.126% |
| Sigachi Industries Limited | 579.88 Million INR | -430.586% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 98.004% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -119.334% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -226.486% |
| Unichem Laboratories Limited | 6.72 Billion INR | 54.254% |
| Wanbury Limited | 1.16 Billion INR | -165.03% |
| Windlas Biotech Limited | 1 Billion INR | -205.69% |
| ZIM Laboratories Limited | 1.01 Billion INR | -203.714% |
| Zydus Lifesciences Limited | 43.17 Billion INR | 92.873% |
| Divi's Laboratories Limited | 14.17 Billion INR | 78.287% |
| Hester Biosciences Limited | 908.84 Million INR | -238.541% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -2.718% |
| Amrutanjan Health Care Limited | 1.09 Billion INR | -179.967% |
| Bal Pharma Limited | 389.89 Million INR | -689.146% |
| Strides Pharma Science Limited | 9.16 Billion INR | 66.419% |
| Venus Remedies Limited | 1.91 Billion INR | -60.561% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -0.078% |
| Nectar Lifesciences Limited | 625.55 Million INR | -391.855% |
| Shilpa Medicare Limited | 2.18 Billion INR | -41.099% |
| Aarti Drugs Limited | 1.16 Billion INR | -163.542% |
| IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | -180.015% |
| Suven Life Sciences Limited | 109.75 Million INR | -2703.462% |
| Ind-Swift Limited | 946.56 Million INR | -225.048% |
| Valiant Laboratories Limited | 36.28 Million INR | -8378.602% |
| J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | 63.446% |
| Solara Active Pharma Sciences Limited | 4.57 Billion INR | 32.817% |
| Themis Medicare Limited | 782.85 Million INR | -293.023% |
| Hikal Limited | 2.48 Billion INR | -23.748% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 85.637% |
| Sequent Scientific Limited | 2.9 Billion INR | -6.03% |
| Novartis India Limited | 470.1 Million INR | -554.499% |
| Wockhardt Limited | 6.4 Billion INR | 51.925% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 78.713% |
| Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -18881.228% |
| Neuland Laboratories Limited | 2.92 Billion INR | -5.019% |
| Morepen Laboratories Limited | 1.98 Billion INR | -54.811% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -646.023% |
| Mangalam Drugs & Organics Limited | 676.14 Million INR | -355.049% |